Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Treatment.com AI, symbol TRUE-CN, is being recognized for its innovative application of artificial intelligence in the medical field. The company's unique approach involves utilizing a medical language model that operates within a finite set of medical data, allowing it to assist healthcare professionals in diagnosing issues efficiently. Its potential applications span across various roles in the medical industry, including doctors, medical office receptionists, 911 dispatchers, and nursing centers. Notably, Treatment.com AI is debt-free and has already secured a significant deal with the University of Edinburgh, which bodes well for its future. With expectations of additional agreements leading to cash flow positivity, experts see strong momentum for the company in the healthcare technology sector.
Treatment.com AI is a Canadian stock, trading under the symbol TRUE-CN on the Canadian Securities Exchange (). It is usually referred to as or TRUE-CN
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
Treatment.com AI was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Treatment.com AI.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
On 2025-04-25, Treatment.com AI (TRUE-CN) stock closed at a price of $0.4.
Using AI to make things more efficient. Medical language model, using a finite universe of only medical data. Helps doctors to diagnose issues. Can be used by medical office receptionists, doctors, 911 dispatchers, nursing centres. Debt free. Deal signed with University of Edinburgh. A few more deals should make them cashflow positive.